pulmicort turbohaler 200 µg/dose pó para inalação
astrazeneca produtos farmacêuticos, lda. - budesonida - pó para inalação - 200 µg/dose - budesonida 0.2 mg/dose - budesonide - n/a - duração do tratamento: longa duração
calquence comprimidos
astrazeneca do brasil ltda - maleato de acalabrutinibe monoidratado -
imfinzi
astrazeneca ab - durvalumab - carcinoma, pulmão de células não pequenas - agentes antineoplásicos - non-small cell lung cancer (nsclc)imfinzi as monotherapy is indicated for the treatment of locally advanced, unresectable non small cell lung cancer (nsclc) in adults whose tumours express pd-l1 on ≥ 1% of tumour cells and whose disease has not progressed following platinum based chemoradiation therapy (see section 5. imfinzi in combination with tremelimumab and platinum-based chemotherapy is indicated for the first-line treatment of adults with metastatic nsclc with no sensitising egfr mutations or alk positive mutations. small cell lung cancer (sclc)imfinzi in combination with etoposide and either carboplatin or cisplatin is indicated for the first-line treatment of adults with extensive-stage small cell lung cancer (es-sclc). biliary tract cancer (btc)imfinzi in combination with gemcitabine and cisplatin is indicated for the first line treatment of adults with unresectable or metastatic biliary tract cancer (btc). hepatocellular carcinoma (hcc)imfinzi in combination with tremelimumab is indicated for the first line treatment of adults with advanced or unresectable hepatocellular carcinoma (hcc).
qtrilmet
astrazeneca ab - metformin hydrochloride, saxagliptin, dapagliflozin - diabetes mellitus, tipo 2 - drogas usadas em diabetes - qtrilmet é indicado em adultos com idade entre 18 e mais anos, com diabetes mellitus tipo 2:para melhorar o controlo glicémico, quando a metformina com ou sem sulphonylurea (su) e saxagliptin ou dapagliflozin não fornece um adequado controlo glicémico. quando já estiver a ser tratada com metformina e saxagliptin e dapagliflozin.
arimidex
astrazeneca do brasil ltda - anastrozol - antineoplasico
casodex
astrazeneca do brasil ltda - bicalutamida - antineoplasico
crestor
astrazeneca do brasil ltda - rosuvastatina cálcica - antilipemicos
daxas
astrazeneca do brasil ltda - roflumilaste - outros produtos para o aparelho respiratorio
fasenra
astrazeneca do brasil ltda - benralizumabe - outros antialergicos
forxiga
astrazeneca do brasil ltda - dapagliflozina - antidiabeticos